Autophagy Inhibition Enhances the Anti-Tumor Activity of Methylseleninic Acid in Cisplatin-Resistance Human Lung Adenocarcinoma Cells
Cisplatin (DDP)-based chemotherapy remains one of the standard treatment options for patients with advanced lung adenocarcinoma (LUAD), and cisplatin resistance is the biggest challenge to this therapy. Autophagy is also closely associated with chemoresistance in LUAD. Desperately need to find a way...
Saved in:
Main Authors: | Ming Xin (Author), Qi Gao (Author), Xindong Xiang (Author), Juanjuan Xu (Author), Yuhan Jiao (Author), Xuan Li (Author), Xianzhen Zhang (Author), Xiuqin Jia (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polyphyllin II induced apoptosis of NSCLC cells by inhibiting autophagy through the mTOR pathway
by: Yuhan Jiao, et al.
Published: (2022) -
Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway
by: Wu T, et al.
Published: (2015) -
Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma
by: Rui Li, et al.
Published: (2020) -
EGFR-IL-6 Signaling Axis Mediated the Inhibitory Effect of Methylseleninic Acid on Esophageal Squamous Cell Carcinoma
by: Yu Wang, et al.
Published: (2021) -
Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer
by: Wujian Zheng, et al.
Published: (2017)